D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Helios Technologies
HLIO
$2.36B
| $9.8M | ﹤0.01% |
109,843
+56,905
| +107% | +$4.37M |
|
1727
Allogene Therapeutics
ALLO
$681M
| $9.8M | ﹤0.01% |
4,710,735
+1,946,959
| +70% | +$4.28M |
|
1728
PUT
Axsome Therapeutics
AXSM
$10.8B
| $9.79M | ﹤0.01% |
+40,000
| New | +$8.67M |
|
1729
Angi Inc
ANGI
$199M
| $9.77M | ﹤0.01% |
1,641,443
-205,094
| -11% | -$1.27M |
|
1730
Armstrong World Industries
AWI
$7.33B
| $9.75M | ﹤0.01% |
+60,755
| New | +$9.93M |
|
1731
Flutter Entertainment
FLUT
$17.4B
| $9.74M | ﹤0.01% |
95,300
-28,095
| -23% | -$2.9M |
|
1732
Organon & Co
OGN
$3.62B
| $9.73M | ﹤0.01% |
718,753
-1,925,799
| -73% | -$23M |
|
1733
Dole
DOLE
$1.32B
| $9.71M | ﹤0.01% |
707,729
+195,945
| +38% | +$2.85M |
|
1734
Indivior Pharmaceuticals
INDV
$4.12B
| $9.68M | ﹤0.01% |
236,034
+32,049
| +16% | +$1.16M |
|
|
MDA
1735
MDA Space Ltd
MDA
$4.78B
| $9.68M | ﹤0.01% |
234,500
+78,483
| +50% | +$2.85M |
|
1736
CALL
Cencora
COR
$63.2B
| $9.68M | ﹤0.01% |
34,200
-4,700
| -12% | -$1.35M |
|
1737
Whirlpool
WHR
$2.56B
| $9.67M | ﹤0.01% |
+245,404
| New | +$11.5M |
|
1738
Varex Imaging
VREX
$780M
| $9.65M | ﹤0.01% |
925,254
-10,579
| -1% | -$114K |
|
1739
PUT
Cleveland-Cliffs
CLF
$7.13B
| $9.65M | ﹤0.01% |
1,027,200
-111,400
| -10% | -$1.23M |
|
1740
Columbia Sportswear
COLM
$2.95B
| $9.63M | ﹤0.01% |
155,801
-214,754
| -58% | -$13.3M |
|
1741
Exponent
EXPO
$3.25B
| $9.63M | ﹤0.01% |
163,892
-28,204
| -15% | -$1.73M |
|
1742
CALL
AT&T
T
$176B
| $9.62M | ﹤0.01% |
464,600
-322,100
| -41% | -$7.99M |
|
1743
Kinsale Capital Group
KNSL
$8.5B
| $9.6M | ﹤0.01% |
29,101
+21,193
| +268% | +$6.82M |
|
1744
Anterix
ATEX
$1.69B
| $9.57M | ﹤0.01% |
92,990
+87,294
| +1,533% | +$5.12M |
|
1745
RxSight
RXST
$265M
| $9.57M | ﹤0.01% |
1,985,215
+25,483
| +1% | +$154K |
|
1746
Frontier Group Holdings
ULCC
$1.37B
| $9.57M | ﹤0.01% |
1,209,528
+1,003,850
| +488% | +$5.18M |
|
1747
Rezolute
RZLT
$441M
| $9.56M | ﹤0.01% |
1,839,357
+73,377
| +4% | +$273K |
|
1748
uniQure
QURE
$3.09B
| $9.56M | ﹤0.01% |
207,629
+46,915
| +29% | +$1.23M |
|
1749
MDU Resources
MDU
$4.12B
| $9.56M | ﹤0.01% |
450,754
-19,834
| -4% | -$431K |
|
1750
Ouster
OUST
$2.63B
| $9.55M | ﹤0.01% |
152,728
-689,361
| -82% | -$23.2M |
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.